Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Beasley

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
International Clinical Psychopharmacology|January 1, 1993
Fluoxetine versus amitriptyline in the treatment of major depression: a multicenter trialC M Beasley, M E Sayler, J H Potvin
The Journal of Clinical Psychiatry|March 1, 1991
Efficacy and safety of morning versus evening fluoxetine administrationR W Usher, C M Beasley, J C Bosomworth
The Journal of Clinical Psychiatry|January 1, 1997
Safety of olanzapineC M Beasley, G D Tollefson, P V Tran
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|September 1, 1993
Fluoxetine compared with imipramine in the treatment of inpatient depression. A multicenter trialC M Beasley, S L Holman, J H Potvin
Schizophrenia Research|July 25, 1997
The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrationsA M Crawford, C M Beasley, G D Tollefson
Psychopharmacology Bulletin|January 1, 1990
Fluoxetine: relationships among dose, response, adverse events, and plasma concentrations in the treatment of depressionC M Beasley, J C Bosomworth, J F Wernicke
Journal of Clinical Psychopharmacology|October 11, 1992
Fluoxetine: activating and sedating effects at multiple fixed dosesC M Beasley, M E Sayler, A M Weiss, et al.
The Gerontologist|November 6, 1998
Elder abuse: two Native American viewsM F Hudson, W D Armachain, C M Beasley, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 31, 1997
Olanzapine versus placebo and haloperidol: quality of life and efficacy results of the North American double-blind trialS H Hamilton, D A Revicki, L A Genduso, et al.
The Journal of Clinical Psychiatry|November 15, 2000
Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day doseC M Beasley, M E Nilsson, S C Koke, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
International Clinical Psychopharmacology|January 1, 1993
Fluoxetine versus amitriptyline in the treatment of major depression: a multicenter trialC M Beasley, M E Sayler, J H Potvin
The Journal of Clinical Psychiatry|March 1, 1991
Efficacy and safety of morning versus evening fluoxetine administrationR W Usher, C M Beasley, J C Bosomworth
The Journal of Clinical Psychiatry|January 1, 1997
Safety of olanzapineC M Beasley, G D Tollefson, P V Tran
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|September 1, 1993
Fluoxetine compared with imipramine in the treatment of inpatient depression. A multicenter trialC M Beasley, S L Holman, J H Potvin
Schizophrenia Research|July 25, 1997
The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrationsA M Crawford, C M Beasley, G D Tollefson
Psychopharmacology Bulletin|January 1, 1990
Fluoxetine: relationships among dose, response, adverse events, and plasma concentrations in the treatment of depressionC M Beasley, J C Bosomworth, J F Wernicke
Journal of Clinical Psychopharmacology|October 11, 1992
Fluoxetine: activating and sedating effects at multiple fixed dosesC M Beasley, M E Sayler, A M Weiss, et al.
The Gerontologist|November 6, 1998
Elder abuse: two Native American viewsM F Hudson, W D Armachain, C M Beasley, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 31, 1997
Olanzapine versus placebo and haloperidol: quality of life and efficacy results of the North American double-blind trialS H Hamilton, D A Revicki, L A Genduso, et al.
The Journal of Clinical Psychiatry|November 15, 2000
Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day doseC M Beasley, M E Nilsson, S C Koke, et al.
Pageof 6